results of the phase ii titan study of caplacizumab in patients with attp
Published 8 years ago • 374 plays • Length 3:56Download video MP4
Download video MP3
Similar videos
-
2:12
results from a phase i trial of tinostamustine in patients with r/r classical hl
-
5:00
long-term results of the phase ii revive study evaluating rusfertide in patients with pv
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
2:04
introducing a phase ib/ii trial to evaluate tasquinimod for the treatment of myelofibrosis
-
1:31
pembrolizumab plus avd in chl: long-term follow-up of a phase ii study
-
1:45
a phase ii study of elritercept for lower-risk mds
-
2:07
phase i/ii study of edit-301, a novel gene-edited autologous hsc medicine, in patients with scd
-
3:40
results of a study evaluating the predictive power of fish markers for pfs in al amyloidosis
-
2:12
results from phase i study of alnuctamab administered intravenously & subcutaneously in r/r myeloma
-
1:17
phase ii study of tosedostat in mds
-
1:18
results of a phase i study of sonrotoclax for the treatment of r/r waldenström’s macroglobulinemia
-
1:59
the optec study: evaluating outpatient step-up administration of teclistamab in pts with r/r myeloma
-
2:58
results of a phase ib study of ibrutinib obinutuzumab in r/r cll
-
3:23
final long-term follow-up results of the relaza2 study: mrd-guided treatment with aza in mds and aml
-
2:28
results from the cartitude-2 trial
-
1:50
novel treatment regimens under investigation for richter's transformation
-
1:44
insights into the phase ii tidal study
-
1:40
results from a phase i/ii study of golcadomide in r/r follicular lymphoma
-
5:24
safety by treatment phase and age when treating flt3-itd-mutated aml with quizartinib and chemo